Takeuchi, Masashi
Kawakubo, Hirofumi
Hoshino, Shota
Matsuda, Satoru
Mayanagi, Shuhei
Irino, Tomoyuki
Fukuda, Kazumasa
Nakamura, Rieko
Wada, Norihito
Kitagawa, Yuko
Article History
Accepted: 19 July 2021
First Online: 12 August 2021
Declarations
:
: Y.K. received lecture fees from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Factory Inc., Shionogi & Co., Ltd., Nippon Covidien Inc., Ono Pharmaceutical Co., Ltd. and Bristol-Myers Squibb K.K. Y.K. was supported by grants from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Yakult Honsha Co. Ltd., Asahi KASEI Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Tsumura & CO., Kyouwa Hakkou Kirin Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., EA Pharma Co., Ltd., Astellas Pharma Inc., Toyama Chemical Co., Ltd., Medicon Inc., Kaken Pharmaceutical Co. Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Factory Inc., Teijin Pharma Limited., Nihon Pharmaceutical Co., Ltd. and Nippon Covidien Inc. Y.K. also holds an endowed chair provided by Chugai Pharmaceutical Co., Ltd. and Taiho Pharmaceutical Co., Ltd., outside the submitted work.